bioRxiv2026
Fecal microbiota transplantation (FMT) has emerged as a highly effective treatment for recurrent Clostridioides difficile infection and is being actively investigated for numerous other conditions. While multi-omics studies have revealed dynamic changes in microbial communities and host metabolism following FMT, existing approaches are primarily descriptive and lack the ability to predict individual patient trajectories or identify early biomarkers of treatment response. Small-sample, multi-omics, longitudinal prediction problems present unique computational challenges: high dimensionality, multi-omics integration, temporal dynamics, and interpretability. Here, we present Hierarchical Multi-Omics Trajectory Prediction (HMOTP), a novel machine learning framework specifically designed for small-sample, multi-omics, longitudinal prediction that addresses these challenges through hierarchical feature construction using domain knowledge, multi-level attention mechanisms, and patient-specific trajectory prediction. HMOTP integrates multi-omics data at multiple biological levels (raw features, aggregated classes/categories, and cross-level interactions) while preserving biological interpretability. The framework employs multi-head attention to learn feature importance at different hierarchy levels and integrates information across omics layers. Patient-specific trajectory prediction enables personalized predictions despite limited sample sizes through transfer learning. We evaluated HMOTP on a cohort of 15 patients with recurrent Clostridioides difficile infection who underwent fecal microbiota transplantation, with comprehensive lipidomics (397 features) and metagenomics (10,634 pathways) profiling at four timepoints spanning six months. Using leave-one-patient-out cross-validation, HMOTP achieved 96.67% {+/-} 10.54% accuracy, outperforming baseline methods including Random Forest (91.33% {+/-} 21.33%) and Logistic Regression (86.33% {+/-} 24.67%). The framework demonstrated robust generalization across timepoints. Through hierarchical interpretability, HMOTP identified key biomarkers and revealed mechanistically informative cross-omics associations, including 324 strong correlations (|r| > 0.7) involving top-predictive biomarkers, demonstrating its utility for both prediction and biological discovery in FMT applications. HMOTP provides a generalizable framework applicable to other small-sample multi-omics problems, offering a powerful tool for personalized medicine applications. Biographical NoteProf. Zhou is an interdisciplinary statistician and machine learning expert whose work develops innovative computational methods for multi-omics integration, biomedical prediction, and precision medicine applications. Key PointsOur novel framework, HMOTP, addresses this challenge through three key innovations: O_LIHierarchical feature construction using domain knowledge - Reduces dimensionality while preserving biological interpretability, unlike PCA-based methods C_LIO_LIMulti-level attention mechanisms - Learns feature importance at multiple biological scales (individual features [->] classes [->] cross-omics interactions) C_LIO_LIPatient-specific trajectory prediction with transfer learning - Enables personalized predictions despite limited sample sizes (parameter-sharing within the cohort, not external pre-training) C_LI